ArticleOphthalmology and therapy2026

Real-Life 1-Year Results and Predictors of Visual Outcome with Intravitreal Faricimab for Treatment of Exudative Neovascular Age-Related Macular Degeneration.

Federico Beretta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.